Page 1 of Clinical Trials for mixed dyslipidemia, 68 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
Last Updated: November 7, 2011
Condition(s): Mixed Dyslipidemia; Hypercholesterolemia
2
Completed
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
Last Updated: April 28, 2008
Condition(s): Mixed Dyslipidemia
3
Completed
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
Last Updated: May 2, 2012
Condition(s): Primary Dyslipidemia; Mixed Dyslipidemia
4
Completed
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
Last Updated: June 9, 2011
Condition(s): Hyperlipidemia; Mixed Dyslipidemia
5
Completed
Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia
Last Updated: April 20, 2012
Condition(s): Dyslipidemia
6
Completed
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
Last Updated: January 18, 2012
Condition(s): Mixed Dyslipidemia
7
Completed
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.
Last Updated: June 3, 2009
Condition(s): Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia
8
Terminated
Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)
Last Updated: April 26, 2012
Condition(s): Primary Hypercholesterolemia; Mixed Dyslipidemia
9
Completed
Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
Last Updated: May 29, 2009
Condition(s): Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia
10
Completed
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
Last Updated: June 1, 2009
Condition(s): Mixed Dyslipidemia; Coronary Heart Disease; Dyslipidemia
11
Completed
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
Last Updated: June 3, 2009
Condition(s): Dyslipidemia; Coronary Heart Disease; Mixed Dyslipidemia
12
Not yet recruiting
Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Last Updated: August 18, 2011
Condition(s): Hypercholesterolemia; Dyslipidemia
13
Terminated
A Study to Evaluate Efficacy and Safety of Extended-Release Niacin (+) Laropiprant (+) Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
Last Updated: April 12, 2012
Condition(s): Primary Hypercholesterolemia; Dyslipidemia
14
Completed
MK0524B Lipid Study
Last Updated: July 30, 2008
Condition(s): Primary Hypercholesterolemia; Mixed Dyslipidemia
15
Completed
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)(COMPLETED)
Last Updated: March 9, 2012
Condition(s): Primary Hypercholesterolemia; Mixed Dyslipidemia
16
Recruiting
Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (Protocol MK-0524A-133 AM1)
Last Updated: April 26, 2012
Condition(s): Primary Hypercholesterolemia; Mixed Dyslipidemia
17
Recruiting
Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Last Updated: March 9, 2012
Condition(s): Lipid Metabolism Disorders
18
Completed
Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia
Last Updated: October 6, 2010
Condition(s): Insulin Sensitivity; Lipoproteins Metabolism; Non Esterified Fatty Acid Kinetics; Lipid Profile
19
Active, not recruiting
An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin
Last Updated: May 14, 2008
Condition(s): Mixed Dyslipidemia
20
Completed
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
Last Updated: August 20, 2008
Condition(s): Type II Diabetes Mellitus; Mixed Dyslipidemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=mixed+dyslipidemia

Page 1 of Clinical Trials for mixed dyslipidemia, 68 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About